# The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

> **NCT02602366** · NA · COMPLETED · sponsor: **CONRAD** · enrollment: 422 (actual)

## Conditions studied

- HIV
- Contraception

## Interventions

- **OTHER:** HEC Placebo Gel
- **OTHER:** Placebo Vaginal Insert
- **OTHER:** Placebo Vaginal Film
- **OTHER:** Placebo Intravaginal ring (IVR)

## Key facts

- **NCT ID:** NCT02602366
- **Lead sponsor:** CONRAD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-06
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-09-30
- **Target enrollment:** 422 (ACTUAL)
- **Last updated:** 2018-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602366, "The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02602366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*